These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 27979321)

  • 1. Analysis of the Cochrane Review: Fibrates for secondary prevention of cardiovascular disease and stroke.
    Pires da Rosa G; Libânio D; Filipe Azevedo L
    Rev Port Cardiol; 2017 Jan; 36(1):55-58. PubMed ID: 27979321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrates for secondary prevention of cardiovascular disease and stroke.
    Wang D; Liu B; Tao W; Hao Z; Liu M
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD009580. PubMed ID: 26497361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrates in the secondary prevention of cardiovascular disease (infarction and stroke). Results of a systematic review and meta-analysis of the Cochrane collaboration.
    Millan J; Pintó X; Brea A; Blasco M; Hernández-Mijares A; Ascaso J; Diaz A; Mantilla T; Pedro-Botet J
    Clin Investig Arterioscler; 2018; 30(1):30-35. PubMed ID: 29395493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrates in primary prevention of cardiovascular disease. Comments on the results of a systematic review of the Cochrane Collaboration.
    Brea A; Millán J; Ascaso JF; Blasco M; Díaz A; Hernández-Mijares A; Mantilla T; Pedro-Botet JC; Pintó X
    Clin Investig Arterioscler; 2018; 30(4):188-192. PubMed ID: 29789212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of cardiovascular disease utilizing fibrates--a pooled meta-analysis.
    Loomba RS; Arora R
    Am J Ther; 2010; 17(6):e182-8. PubMed ID: 20535009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus--a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Arora RR
    Int J Cardiol; 2010 May; 141(2):157-66. PubMed ID: 19232762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of fibrates in the prevention of cardiovascular disease--a pooled meta-analysis of long-term randomized placebo-controlled clinical trials.
    Saha SA; Kizhakepunnur LG; Bahekar A; Arora RR
    Am Heart J; 2007 Nov; 154(5):943-53. PubMed ID: 17967602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid management in the prevention of stroke: a meta-analysis of fibrates for stroke prevention.
    Zhou YH; Ye XF; Yu FF; Zhang X; Qin YY; Lu J; He J
    BMC Neurol; 2013 Jan; 13():1. PubMed ID: 23282097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fibrates in kidney disease: a systematic review and meta-analysis.
    Jun M; Zhu B; Tonelli M; Jardine MJ; Patel A; Neal B; Liyanage T; Keech A; Cass A; Perkovic V
    J Am Coll Cardiol; 2012 Nov; 60(20):2061-71. PubMed ID: 23083786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis.
    Jun M; Foote C; Lv J; Neal B; Patel A; Nicholls SJ; Grobbee DE; Cass A; Chalmers J; Perkovic V
    Lancet; 2010 May; 375(9729):1875-84. PubMed ID: 20462635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hypertriglyceridemia with fibric acid derivatives: impact on lipid subfractions and translation into a reduction in cardiovascular events.
    McCullough PA; Ahmed AB; Zughaib MT; Glanz ED; Di Loreto MJ
    Rev Cardiovasc Med; 2011; 12(4):173-85. PubMed ID: 22249508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus: meta-analysis of randomised controlled trials.
    Allemann S; Diem P; Egger M; Christ ER; Stettler C
    Curr Med Res Opin; 2006 Mar; 22(3):617-23. PubMed ID: 16574044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperlipidaemia and cardiovascular disease: do fibrates have a role?
    Saha SA; Arora RR
    Curr Opin Lipidol; 2011 Aug; 22(4):270-6. PubMed ID: 21519250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: Statins or Fibrates for the Primary Prevention of Stroke in the Elderly. Faith Makes Some Things Achievable, But Not AII.
    Athyros VG; Tziomalos K; Karagiannis A
    Curr Vasc Pharmacol; 2015; 13(6):696-8. PubMed ID: 26459809
    [No Abstract]   [Full Text] [Related]  

  • 15. [Part I. Fibrates in primary and secondary prevention].
    Clin Investig Arterioscler; 2016 Jul; 28 Suppl 3():3-10. PubMed ID: 27473465
    [No Abstract]   [Full Text] [Related]  

  • 16. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrate therapy and flow-mediated dilation: A systematic review and meta-analysis of randomized placebo-controlled trials.
    Sahebkar A; Giua R; Pedone C; Ray KK; Vallejo-Vaz AJ; Costanzo L
    Pharmacol Res; 2016 Sep; 111():163-179. PubMed ID: 27320045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins for Primary Prevention of Cardiovascular Disease in Elderly Patients: Systematic Review and Meta-Analysis.
    Teng M; Lin L; Zhao YJ; Khoo AL; Davis BR; Yong QW; Yeo TC; Lim BP
    Drugs Aging; 2015 Aug; 32(8):649-61. PubMed ID: 26245770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue ACE inhibitors for secondary prevention of cardiovascular disease in patients with preserved left ventricular function: a pooled meta-analysis of randomized placebo-controlled trials.
    Saha SA; Molnar J; Arora RR
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):192-204. PubMed ID: 17875946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fibrates: their prescription must be restricted].
    Béliard-Lasserre S
    Rev Prat; 2015 Dec; 65(10):1243-4. PubMed ID: 26979011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.